Evidence map›Paper›PMID 31859529›Full record

ArticleDiabetes technology & therapeutics2020

Transforming Performance of Clinical Trials in Pediatric Type 2 Diabetes: A Consortium Model.

Michelle Van Name, Georgeanna Klingensmith, Bryce Nelson, Kupper Wintergerst, Jeffrey Mitchell, Kathryn Norris, William V Tamborlane, Pediatric Diabetes Consortium

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes technology & therapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Michelle Van NameDepartment of Pediatrics, Yale University, New Haven, Connecticut.
Georgeanna KlingensmithDepartment of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado, Aurora, Colorado.
Bryce NelsonDepartment of Pediatrics, Virginia Commonwealth University, Richmond, Virginia.
Kupper WintergerstWendy Novak Diabetes Center, Department of Pediatrics, University of Louisville, Louisville, Kentucky.
Jeffrey MitchellThe Emmes Company LLC, Rockville, Maryland.
Kathryn NorrisThe Emmes Company LLC, Rockville, Maryland.
William V TamborlaneDepartment of Pediatrics, Yale University, New Haven, Connecticut.
Pediatric Diabetes Consortium

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Richard A Flavell · 1993 to 2026
$44.0M
NCATS NIH HHS UL1 TR001863NIDDK NIH HHS P30 DK045735
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 2Models, OrganizationalBiomedical ResearchChildClinical Trials, Phase III as TopicCooperative BehaviorFemaleHumansMaleResearch DesignClinical trialsPediatric Diabetes ConsortiumPediatric type 2 diabetesT2DM

Identifiers

PMID31859529
PMCPMC7869879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.